BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

LAB Research Inc. to Present at Upcoming UBS 2009 Global Healthcare Services Conference in New York


2/9/2009 11:19:42 AM

www.labresearch.com

Toronto Stock Exchange Symbol: LRI

LAVAL, QC, Feb. 9 /PRNewswire-FirstCall/ - LAB Research Inc. ("LAB Research" or the "Company"), a Canadian based global non-clinical contract research organization ("CRO"), today announced that Mr. Luc Mainville, Chief Executive Officer of the Company, will be presenting at the UBS 2009 Global Healthcare Services Conference on Wednesday February 11, 2009 at 9.30 am at the Waldorf Astoria Hotel in New York.

A live webcast of the presentation will be available on LAB Research website in the Investors section at www.labresearch.com

About LAB Research Inc.:

LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.

LAB Research's shares trade on The Toronto Stock Exchange ("TSX") under the symbol "LRI", with 18.1 million shares outstanding.

This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.

CONTACT: visit LAB Research's website at www.labresearch.com, or contact:
Luc Mainville, Chief Executive Officer, (450) 973-2240, (ext. 1206),
mainvillel@labresearch.com; Frederic Dumais, Jasmin-Dumais Financial
Communications, (514) 862-1251, fred@comjamais.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES